Unlike native GLP-1, which has a half-life of only 1-2 minutes due to rapid enzymatic cleavage, the unique lipidization of the Semaglutide Peptide allows it to strongly bind to serum albumin, facilitating a substantially prolonged half-life for extended observational studies
Wegovy is approved for weight loss and Ozempic is approved to treat type 2 diabetes mellitus
People drawn to microdosing often want the metabolic benefits of these therapies at a level that feels more tolerable: fewer side effects gentler appetite reduction or a more gradual experience overall Understanding what makes these two medications similar, and what sets them apart, is key to understanding why the comparison matters
What Are GLP-1 Receptor Agonists
Without our team, we wouldnt be able to provide our clients with anything close to the level of service they receive when they work with us
Report the product to the FDA MedWatch program at www.fda.gov/medwatch or by calling 1-800-FDA-1088